Published in Ann Rheum Dis on July 01, 2007
Current and novel therapeutics in the treatment of systemic lupus erythematosus. J Allergy Clin Immunol (2011) 1.13
Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy. Rheumatol Int (2009) 0.78
Rituximab in childhood lupus myocarditis. Rheumatol Int (2011) 0.78
Cardiac involvement in systemic lupus erythematosus. Lupus (2005) 2.08
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum (2004) 1.89
Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol (1999) 1.13
Four cases of Kawasaki syndrome complicated with myocarditis. Circ J (2006) 0.96
Specific cardiomyopathy in lupus patients: report of three cases. Joint Bone Spine (2004) 0.86
Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus. Autoimmun Rev (2005) 0.86
Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis. Lupus (2012) 1.42
Sulphamethoxazole-trimethoprim in the treatment of limited paranasal Wegener's granulomatosis. Rheumatology (Oxford) (2002) 1.41
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. Lupus (2013) 1.36
Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) (2005) 1.35
The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) (2000) 1.25
Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus. Lupus (2003) 1.21
Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis (2003) 1.14
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis (2006) 1.00
Intracerebral arterial stenosis with neurological events associated with antiphospholipid syndrome. Rheumatology (Oxford) (2005) 0.99
Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol (1993) 0.99
Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford) (2003) 0.99
Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) (2004) 0.96
Replacement of a labile aspartyl residue increases the stability of human epidermal growth factor. Biochemistry (1990) 0.95
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol (1994) 0.93
Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann N Y Acad Sci (2005) 0.93
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis (2003) 0.93
Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis (1992) 0.91
Mathematical analysis of antigen selection in somatically mutated immunoglobulin genes associated with autoimmunity. Lupus (2010) 0.89
Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis (2005) 0.89
Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis (2012) 0.88
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford) (2002) 0.88
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. Ann Rheum Dis (2004) 0.88
Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin Exp Rheumatol (1992) 0.87
Mechanisms of pollution-induced airway disease: in vitro studies in the upper and lower airways. Allergy (1997) 0.87
Effect of temperature on an enzyme assay to detect fenitrothion resistance in Anopheles albimanus mosquitos. Bull World Health Organ (1989) 0.87
Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study. Lupus (1991) 0.87
Difficult asthma or Churg-Strauss syndrome? BMJ (1999) 0.86
Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome. Ann Rheum Dis (2007) 0.85
The NIH pulse cyclophosphamide regime: the end of an era? Lupus (2004) 0.84
Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis. Rheumatology (Oxford) (2008) 0.84
Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis. Lupus (2013) 0.84
Mycophenolate mofetil treatment in resistant myositis. Rheumatology (Oxford) (2006) 0.83
Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy. Rheumatology (Oxford) (2005) 0.83
Renal artery stenosis: a new facet of the antiphospholipid (Hughes) syndrome. Lupus (2003) 0.82
Vasculitis, antiphospholipid antibodies, and renal artery stenosis. Ann Rheum Dis (2005) 0.82
Atherogenesis in rheumatology. Lupus (2006) 0.82
Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford) (2004) 0.82
Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies. Clin Exp Rheumatol (2006) 0.81
Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy. HIV Med (2011) 0.81
Elevated levels of activated CD4 T cells in common variable immunodeficiency: association with clinical findings. Allergol Immunopathol (Madr) (2006) 0.80
Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy. Eur J Clin Microbiol Infect Dis (2011) 0.79
Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford) (2004) 0.79
Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease. Clin Rheumatol (2006) 0.79
Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome. Rheumatology (Oxford) (2007) 0.78
Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: the HGM-3 index. HIV Med (2009) 0.78
Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection. Transpl Infect Dis (2008) 0.78
Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura. Lupus (2007) 0.78
Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: a controlled study. Ann Rheum Dis (2006) 0.77
Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies. Ann Rheum Dis (2005) 0.77
Rates of tetanus protection and transplacental tetanus antibody transfer in pregnant women from different socioeconomic groups in Peru. Clin Diagn Lab Immunol (1996) 0.77
Increased risk of vascular complications in Takayasu's arteritis patients with positive lupus anticoagulant. Scand J Rheumatol (2014) 0.77
Treatment of mesenteric angina with prolonged anticoagulation in a patient with antiphospholipid (Hughes) syndrome and coeliac artery stenosis. Ann Rheum Dis (2006) 0.77
Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome. Lupus (2008) 0.77
IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients. J Viral Hepat (2013) 0.77
A case of mistaken identity: subacute bacterial endocarditis associated with p-antineutrophil cytoplasmic antibody. BMJ Case Rep (2010) 0.77
Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis. Ann Rheum Dis (2008) 0.76
The point prevalence of an abnormal ankle-brachial index in antiphospholipid antibody negative patients with livedo reticularis: a controlled study. Ann Rheum Dis (2008) 0.76
Pyridoxine toxicity courtesy of your local health food store. Ann Rheum Dis (2006) 0.76
Antiendothelial cell antibodies (AECA) in patients with uveoretinitis. Clin Rev Allergy Immunol (1997) 0.76
Training model for "beating-heart" coronary artery anastomoses. Ann Thorac Surg (1999) 0.75
Rheumatology. Postgrad Med J (1991) 0.75
Fever, haemoptysis and a mass in the heart. J R Soc Med (2007) 0.75
Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcón. Arthritis Rheum (2002) 0.75
Limited access myocardial revascularization. Tex Heart Inst J (1996) 0.75
Spontaneous pneumomediastinum in two stowaways. Br Med J (Clin Res Ed) (1986) 0.75
Aortic cannulation in organ donors with pathology of the infrarenal aorta. J Am Coll Surg (1998) 0.75
New Cadaveric Organ Donation Program at the Social Security Mexican Institute: initial experience. Transplant Proc (1997) 0.75
Legal basis for cadaver donation in Mexico: a simple diagram that facilitates the legal procedure, initial experience. Transplant Proc (1997) 0.75
Dermatomyositis developing in a Duchenne muscular dystrophy carrier. Rheumatology (Oxford) (2004) 0.75
Immunosuppression (Neoral vs Sandimmune) in pediatric kidney transplantation. Transplant Proc (1997) 0.75
Complement consumption associated with eczematous cutaneous reaction during infusions of high doses of intravenous immunoglobulin. Br J Dermatol (2004) 0.75
[Genital amebiasis]. Ginecol Obstet Mex (1971) 0.75
[Problem based learning in the teaching of physics to medical students. Comparison with traditional teaching]. Rev Med Chil (2001) 0.75
Assessment of the water self-purification capacity on a river affected by organic pollution: application of chemometrics in spatial and temporal variations. Environ Sci Pollut Res Int (2014) 0.75
Fibrin deposition in SLE glomerulonephritis. Lupus (1993) 0.75
Cardiac complications of Behcet's disease. Clin Rheumatol (2014) 0.75
Renal microinfarction in Behçet's disease. Rheumatology (Oxford) (2003) 0.75
[Biological importance of the trace elements]. Rev Dent Chile (1966) 0.75
New Donation Program at a Mexican social security institution: a Mexican model of cadaver donation and organ sharing--initial experience. Transplant Proc (1997) 0.75
[Colorimetric determination of tryptophan in foods]. Arch Latinoam Nutr (1982) 0.75
[Formulation of a rice-based beverage of high nutritive value]. Arch Latinoam Nutr (1981) 0.75
[Formulation and evaluation of a beverage based on whole milk and precooked rice flour]. Arch Latinoam Nutr (1993) 0.75
Antiendothelial cell antibodies in chronic urticaria. Clin Exp Rheumatol (1995) 0.75
Pancytopenia in ANCA associated vasculitis: response to immunosuppressive therapy. Clin Exp Rheumatol (2003) 0.75
[Partial transposition of the major vessels (embryology, pathological anatomy and classification)]. Kardiologiia (1981) 0.75
MALToma and lupus. Lupus (2005) 0.75
Hepatomegaly as a rare presentation of Churg-Strauss syndrome. Rheumatology (Oxford) (2005) 0.75
[Systemic autoimmune disease in patients with uveitis]. Arch Soc Esp Oftalmol (2006) 0.75
Late development of aortic pseudoaneurysm after coarctation repair with fistulization to the bronchial tree. A case report. Heart Surg Forum (1998) 0.75